Indie-Looking Brands Are Now the Core Strategy, Not Cute Extras
The indie beauty brands strategy now refers to how major beauty conglomerates keep smaller, acquisition-born labels operating with entrepreneurial speed and autonomy, so they can target niche beauty market segments, test innovations faster than legacy names, and preserve the independent feel that drives loyalty and pricing power across a crowded category. Estée Lauder Companies’ decision not to sell Too Faced, Smashbox, and Dr. Jart marks a clear break from the old playbook of trimming a beauty conglomerate portfolio when brands underperform financially. Instead of offloading them after receiving final bids for a combined package worth an estimated USD 100–199.99 million (approx. RM460–RM919 million), the group will restructure around leaner teams and tailored business models. That is not a defensive wobble; it is a deliberate bet that indie-style agility is now worth more than short-term sale proceeds.
Inside Estée Lauder’s U-Turn: Paying for Agility Over Exit Cash
When Estée Lauder Too Faced, Smashbox and Dr. Jart were quietly shopped to buyers, it looked like textbook portfolio rationalization: three underperforming acquisitions from the 2010s neatly bundled up for sale. The brands had been struggling, with makeup and skin care segments broadly in decline and each label facing its own financial shortcomings. Then the company reversed course. An internal document confirmed the sale was off and the brands would be restructured instead. Stéphane de La Faverie framed the pivot bluntly: the brands have different strengths and competitive dynamics, so they need tailored business models to unlock growth. At the same time, the group expects to spend up to USD 1.75 billion (approx. RM8.05 billion) on a wider restructuring plan, far above the original USD 500–700 million (approx. RM2.30–RM3.22 billion) estimate. That quote-worthy figure shows how seriously Estée Lauder is willing to fund agility rather than cash out.
From Heavyweight to Indie-Inspired Operator
The most telling line in Estée Lauder’s internal document is not about cost cutting but mindset: “By adopting the speed, agility, and entrepreneurial mindset of successful beauty indies, we are evolving how we operate”. That sentence makes explicit what many conglomerates have only hinted at: indie brands are no longer decorative; they are strategic engines. Instead of forcing Too Faced, Smashbox and Dr. Jart into a one-size-fits-all corporate template, the group will break them into different operational setups. Too Faced moves its headquarters from Los Angeles to New York with a smaller team and joins an existing makeup cluster with Bobbi Brown and MAC. Smashbox stays in Los Angeles, also with a reduced team. Dr. Jart remains in South Korea, continuing under the same global brand lead and creative head, Ye Jin Kim, who has steered it for over four years. The message is clear: structure follows brand, not the other way around.
Why Retaining Underperformers Can Still Be a Power Move
On paper, selling three underperforming labels for a low nine-figure sum looks neat; in reality, it risks giving up hard-won access to the niche beauty market. Indie-feeling brands reach consumers who often avoid corporate mastheads yet still buy from them when the product story feels personal. Estée Lauder’s choice to keep Too Faced, Smashbox and Dr. Jart, even while its broader makeup and skin care segments face declines, shows that the company values that reach more than a tidy balance sheet. Rather than seeing these brands as drag, it is treating them as experimental units inside a large system, where smaller teams can push faster innovation and more direct consumer connections. That is the opposite of traditional portfolio pruning: it accepts short-term pain in exchange for a chance to rebuild relevance with consumers whose preferences now change faster than legacy cycles.
What This Signals for Big Beauty’s Next Playbook
Estée Lauder’s retreat from a sale, plus its earlier decision to abandon a merger with another major beauty player after complex deal dynamics, including issues around Charlotte Tilbury’s change-of-control clause, suggests conglomerates are reevaluating how scale should look. Bigger is no longer automatically better; smarter, more flexible scale is. By choosing restructuring over divestment, and indie-style autonomy over strict centralization, the company is rewriting what a beauty conglomerate portfolio is for. It is not merely a collection of assets but a network of different-paced brands that can test and respond to consumer shifts. Expect other giants to watch what happens to Estée Lauder Too Faced, Smashbox and Dr. Jart closely. If leaner, entrepreneurial setups restore growth to these struggling labels, the industry will have clear proof that keeping indie brands close—and letting them act indie—is more powerful than selling them off for short-term relief.
